Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
Breast cancer is the most frequent malignant neoplastic disease in women, with an estimated 2.3 million cases in 2020 worldwide. Its treatment depends on characteristics of the patient and the tumor. In the latter, characteristics include cell type and morphology, anatomical location, and immunophen...
Saved in:
Main Authors: | Gabriel Méndez-Valdés (Author), Francisca Gómez-Hevia (Author), Maria Chiara Bragato (Author), José Lillo-Moya (Author), Catalina Rojas-Solé (Author), Luciano Saso (Author), Ramón Rodrigo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy
by: Catalina Rojas-Solé, et al.
Published: (2024) -
Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
by: José Lillo-Moya, et al.
Published: (2021) -
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
by: Thawatchai Khuanjing, et al.
Published: (2023) -
Histopathological Study on The Effect of Neuregulin-1 Against Cardiotoxicity Induced By Trastuzumab in Adult Mice
by: yousuf gays majeed, et al.
Published: (2018) -
Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
by: Iacopo Fabiani, et al.
Published: (2020)